Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2013 1
2015 1
2016 2
2017 2
2018 5
2019 1
2020 4
2021 2
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean so young moon (99 results)?
Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study.
Baek DW, Park HS, Sohn SK, Kim DY, Kim I, Ahn JS, Do YR, Lee SR, Eom HS, Lee WS, Kim SH, Lee HS, Lee YJ, Moon JH, Lee JH; Adult Acute Lymphoblastic Leukemia Working Party, the Korean Society of Hematology. Baek DW, et al. Korean J Intern Med. 2023 Sep;38(5):734-746. doi: 10.3904/kjim.2022.401. Epub 2023 Jun 20. Korean J Intern Med. 2023. PMID: 37334511 Free PMC article. Clinical Trial.
Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170).
Song GY, Lee JJ, Moon JH, Kim D, Kim MK, Kim HJ, Mun YC, Lee WS, Do YR, Lee JH, Jung SH, Kim JS. Song GY, et al. Front Oncol. 2023 Oct 25;13:1209110. doi: 10.3389/fonc.2023.1209110. eCollection 2023. Front Oncol. 2023. PMID: 37965454 Free PMC article.
Evaluation of the R2-ISS in real-world patients with newly diagnosed multiple myeloma: A nationwide cohort study by the Korean Multiple Myeloma Working Party (KMM 2202).
Cho H, Kim K, Yoon SE, Jung SH, Lee JJ, Moon JH, Cho HJ, Lee HS, Kang KW, Kim SY, Eom HS, Mun YC, Park YH, Yoon SS, Do YR, Lee WS, Min CK, Yoon DH. Cho H, et al. Hemasphere. 2024 Jan 26;8(1):e33. doi: 10.1002/hem3.33. eCollection 2024 Jan. Hemasphere. 2024. PMID: 38434530 Free PMC article. No abstract available.
24 results